Gynuity Health Projects

Resources

Resources by Topic

Medical Abortion (View all)

Misoprostol for Early Abortion

Map of Mifepristone Approvals

List of Mifepristone Approvals

Medical Abortion Guidebook

Improving Current Therapies and Exploring New Options in Abortifacient Technology

Mifepristone medical abortion in Albania

Regimens of misoprostol with mifepristone for early medical abortion

Early pregnancy termination

Use of sequential serum hCG and sonography for medical abortion only when indicated

Are two doses of misoprostol after mifepristone for early abortion better than one?

Alternatives to mifepristone for early medical abortion

Mifepristone for late first trimester abortion

Can mifepristone medical abortion be simplified?

Methotrexate compared to misoprostol alone for early medical abortion

Assessment of pregnancy duration among termination of pregnancy clients in South Africa

Abortion is for women

The supreme court and the partial-birth abortion ban act of 2003

Medical Abortion Program Brief

Choices for Medical Abortion Introduction in Brazil, Colombia, Mexico and Peru

Supervision for use of mifepristone medical abortion

Integrating medical abortion into safe abortion services in South Africa

Abortion in the Middle East and North Africa

Expanding Choice in Abortion Services in Armenia

Two distinct oral routes of misoprostol in mifepristone medical abortion

Abortion and sex determination

Sublingual misoprostol after mifepristone

Non-physician clinicians can safely provide first trimester medical abortion

Oral vs. sublingual misoprostol (400 mcg) following 200 mg mifepristone

Increasing women’s choices in medical abortion in Turkey

Knowledge, attitudes, and practice of abortion among women and doctors in Armenia

Modern Methods of Abortion

Acceptability and feasibility of medical abortion in Nepal

Alternatives to Routine Follow-Up for Early Medical Abortion

Home administration of misoprostol for early medical abortion in India

ICMA Third International Conference

Unsafe Abortion and Strategies to Reduce its Impact on Women’s Lives

Medical abortion: Outcomes in a family medicine setting

Abortion With Self-Administered Misoprostol: A Guide For Women

Self-induction of abortion among women in the United States

Buccal vs. sublingual misoprostol after mifepristone for medical abortion

Alternatives to routine ultrasound for eligibility assessment prior to medical abortion

Introduction and provision of medical abortion: A tale of two countries

Medical abortion for adolescents

Comparing two early medical abortion regimens: Mifepristone+misoprostol vs. misoprostol alone

Review of the Literature on Patient Satisfaction with Early Medical Abortion

Mifepristone and Misoprostol Compared With Misoprostol Alone for Second-trimester Abortion

Abortion: What is the problem?

The comparative safety of legal induced abortion and childbirth in the United States

Feticidal digoxin before D&E

Comparison of regimens for home-based early medical abortion in Tunisia and Vietnam

Two doses of buccal misoprostol following mifepristone

Use of Medicines Changing the Face of Abortion

Clinic-level introduction of medical abortion in Vietnam

Outpatient medical abortion through 70 days

At-home semi-quantitative pregnancy tests as replacement for clinical follow-up of medical abortion

Armenia: A Way to Make Abortion Safer

First-trimester medical abortion with mifepristone 200 mg and misoprostol: A systematic review

Mifepristone-Misoprostol for early Medical Abortion in Uzbekistan

Efficacy and acceptability of early mifepristone-misoprostol medical abortion in Ukraine

Simplified medical abortion using a semi-quantitative pregnancy test for home-based follow-up

Results from a study using misoprostol for management of incomplete abortion in Vietnamese hospitals

Acceptability and Feasibility of Mifepristone-Misoprostol For Menstrual Regulation in Bangladesh

Prophylactic compared with therapeutic Ibuprofen analgesia in first-trimester medical abortion

Acceptability of home use of mifepristone for medical abortion

Medical abortion: A path to safe, high-quality abortion care in Latin America and the Caribbean

A two-pill sublingual misoprostol outpatient regimen following mife for MA through 70 days’ LMP

Pregnancy Termination/Abortion

Acceptability and feasibility of phone follow-up after early medical abortion in Vietnam

Mife plus miso or miso-alone for abortion induction in pregnancies 12-24 weeks’ LMP

FAQ on Misoprostol Detection in Blood

Acceptability and feasibility of medical abortion with mifepristone and misoprostol in Nigeria

Medical abortion work in Eastern Europe/Central Asia

Decentralizing postabortion care in Senegal with misoprostol for incomplete abortion

Efficacy and acceptability of a mifepristone-misoprostol combined regimen for early induced abortion

Acceptability and feasibility of mifepristone medical abortion in the early first trimester in Azerb

First experience of the use of misoprostol as post-abortion care in Libreville, Gabon.

Claims of misoprostol use based on blood sampling should be viewed with skepticism

What happens when we routinely give doxycycline to medical abortion patients?

Knowledge of Abortion Laws and Services among Low-Income Women in Three United States Cities

The introduction of first trimester medical abortion in Armenia

Phone follow-up with SQPT after medical abortion in Moldova and Uzbekistan

Safety, efficacy and acceptability of outpatient mifepristone-misoprostol MA through 70 days

A prospective open-label study of home use of mifepristone for medical abortion in Nepal

Adjunct mifepristone for cervical preparation prior to dilation and evacuation: a randomized trial

Early Medical Abortion without Prior Ultrasound

Off-label indications for mifepristone in gynecology and obstetrics

Reaching women where they are

Outpatient medical abortion is safe and effective through 70 days gestation

A double-blind randomized controlled trial of mifepristone or placebo before buccal misoprostol

Fifteen years: looking back and looking forward

Is It Safe to Provide Abortion Pills Over The Counter?

A prospective, non-randomized study of home-use of mifepristone for medical abortion in the U.S.

Home use of urine pregnancy tests for medical abortion follow-up

Cervical Preparation Before Dilation and Evacuation Using Adjunctive Misoprostol or Mifepristone

Continuing pregnancy after mifepristone and “reversal” of first-trimester medical abortion

If we can do it for misoprostol, why not for mifepristone?

Mifepristone label laws and trends in use: recent experiences in four US states

Effect of Immediate Compared with Delayed Insertion of Etonogestrel Implants

Vaginal and Rectal Clostridium sordellii and Clostridium perfringens Presence Among Women in the US

Medical abortion